bearish

HJ Science

HJ Science (华健未来) Pre-IPO: Thoughts on Valuation

157 Views08 Jun 2026 10:00
HJ Science is seeking to raise at least USD100m via a Hong Kong listing. We value the four pipeline assets at USD317m on a China SOTP basis.
What is covered in the Full Insight:
  • Introduction to HJ Science's Valuation Strategy
  • Asset Analysis: HJ787 in Dermatology
  • Market Positioning: HJ891 in NSCLC
  • Opportunities in Type 2 Diabetes: HJ178
  • Hepatocellular Carcinoma Treatment: HJ197
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
x